SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-16-145694
Filing Date
2016-09-20
Accepted
2016-09-20 16:02:02
Documents
2
Period of Report
2016-09-12

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1550
2 EX-24 ex-24.htm EX-24 9653
  Complete submission text file 0001104659-16-145694.txt   12644
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Issuer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MD 02142
Business Address
Menes Remi A (Reporting) CIK: 0001684866 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34921 | Film No.: 161893953